These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 18847403

  • 41. Antibiotic resistance in Enterococcus faecium clinical isolates.
    Cattoir V, Giard JC.
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):239-48. PubMed ID: 24392717
    [Abstract] [Full Text] [Related]

  • 42. Virulence and antimicrobial resistance in clinical Enterococcus faecium.
    Billström H, Lund B, Sullivan A, Nord CE.
    Int J Antimicrob Agents; 2008 Nov; 32(5):374-7. PubMed ID: 18715765
    [Abstract] [Full Text] [Related]

  • 43. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L, Nicola L, De Vecchi E.
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [Abstract] [Full Text] [Related]

  • 44. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J, Zick G, Klare I, Konstabel C, Weiler N, Sahly H.
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
    [Abstract] [Full Text] [Related]

  • 45. In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.
    Elsner HA, Sobottka I, Feucht HH, Claussen M, Kaulfers PM, Laufs R, Mack D.
    Chemotherapy; 2000 Dec; 46(2):104-10. PubMed ID: 10671760
    [Abstract] [Full Text] [Related]

  • 46. Invasive infections due to vancomycin-resistant enterococci in adult patients.
    Jean SS, Fang CT, Wang HK, Hsue PR, Chang SC, Luh KT.
    J Microbiol Immunol Infect; 2001 Dec; 34(4):281-6. PubMed ID: 11825009
    [Abstract] [Full Text] [Related]

  • 47. Antimicrobial pressure and the emergence and spread of multiresistant enterococci.
    Rice LB.
    Postgrad Med; 2001 Feb; 109(2 Suppl):22-31. PubMed ID: 19667554
    [Abstract] [Full Text] [Related]

  • 48. [Susceptibility of Enterococcus genus to new antimicrobial agents].
    Sánchez-Molina MI, Martín D, Valladares C, Gastañares MJ, Torres C, Borque L.
    Rev Esp Quimioter; 2004 Jun; 17(2):184-8. PubMed ID: 15470513
    [Abstract] [Full Text] [Related]

  • 49. Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.
    Yim J, Smith JR, Rybak MJ.
    Pharmacotherapy; 2017 May; 37(5):579-592. PubMed ID: 28273381
    [Abstract] [Full Text] [Related]

  • 50. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
    D'Arezzo S, Mazzarelli A, Venditti C, Nisii C, Petrosillo N, De Giuli C, Vulcano A, Paglia MG, Bordi E, Di Caro A, Taglietti F.
    Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
    [Abstract] [Full Text] [Related]

  • 51. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
    Tamma PD, Hsu AJ.
    Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503
    [Abstract] [Full Text] [Related]

  • 52. Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin.
    Schutt AC, Bohm NM.
    Ann Pharmacother; 2009 Dec; 43(12):2108-12. PubMed ID: 19887592
    [Abstract] [Full Text] [Related]

  • 53. Unusual increase of vancomycin-resistant Enterococcus faecium but not Enterococcus faecalis at a university hospital in Taiwan.
    Chiang PC, Wu TL, Su JY, Huang YC, Chiu YP, Chia JH, Kuo AJ, Su LH.
    Chang Gung Med J; 2007 Dec; 30(6):493-503. PubMed ID: 18350732
    [Abstract] [Full Text] [Related]

  • 54. Trimethoprim resistance genes in vancomycin-resistant Enterococcus faecium clinical isolates from France.
    Cattoir V, Huynh TM, Bourdon N, Auzou M, Leclercq R.
    Int J Antimicrob Agents; 2009 Oct; 34(4):390-2. PubMed ID: 19619988
    [No Abstract] [Full Text] [Related]

  • 55. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
    Allen GP, Bierman BC.
    Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
    [Abstract] [Full Text] [Related]

  • 56. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.
    Jones RN.
    Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S13-24. PubMed ID: 16323115
    [Abstract] [Full Text] [Related]

  • 57. Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals.
    Lester CH, Sandvang D, Olsen SS, Schønheyder HC, Jarløv JO, Bangsborg J, Hansen DS, Jensen TG, Frimodt-Møller N, Hammerum AM, DANRES Study Group.
    J Antimicrob Chemother; 2008 Dec 01; 62(6):1203-6. PubMed ID: 18765412
    [Abstract] [Full Text] [Related]

  • 58. Susceptibility profile of Enterococcus faecalis isolated at the Lagos University Teaching Hospital, Nigeria.
    Iregbu KC, Ogunsola FT, Odugbemi TO.
    Niger Postgrad Med J; 2002 Sep 01; 9(3):125-8. PubMed ID: 12501265
    [Abstract] [Full Text] [Related]

  • 59. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.
    Munoz-Price LS, Lolans K, Quinn JP.
    Clin Infect Dis; 2005 Aug 15; 41(4):565-6. PubMed ID: 16028170
    [No Abstract] [Full Text] [Related]

  • 60. Enterococci: susceptibility patterns and therapeutic options.
    Nicoletti G, Stefani S.
    Eur J Clin Microbiol Infect Dis; 1995 Aug 15; 14 Suppl 1():S33-7. PubMed ID: 7729470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.